Related Experiment Video
Updated: Aug 9, 2026

Method for Simultaneous fMRI/EEG Data Collection during a Focused Attention Suggestion for Differential Thermal Sensation
Published on: January 5, 2014
Hypnagogic and hypnopompic hallucinations during amitriptyline treatment
Amitriptyline treatment can cause hypnagogic or hypnopompic visual hallucinations. These benign hallucinations are temporary and patients should be informed to avoid premature treatment termination.
Area of Science:
- Neuroscience
- Pharmacology
- Psychiatry
Background:
- Amitriptyline is a commonly prescribed antidepressant.
- Visual hallucinations are not a typical side effect of amitriptyline.
Observation:
- Four patients on amitriptyline reported experiencing hypnagogic or hypnopompic visual hallucinations.
- These hallucinations were vivid, projected into external space, and initially perceived as real.
Findings:
- Patients quickly recognized the unreality of the hallucinations.
- The phenomena may be linked to amitriptyline's effects on brain function, sleep patterns, and clinical recovery.
Implications:
- Informing patients about these benign visual disturbances is crucial.
- This knowledge can prevent unnecessary discontinuation of amitriptyline therapy.
More Related Videos
09:06Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
Related Concept Videos
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Altered States of Awareness
The ingestion of substances like stimulants or hallucinogens leads to chemical alterations in the brain that...
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Narcolepsy